MAP1LC3A and depressive symptom measurement: Both Δ502-505 and T532A, two GPR50 variations genetically associated with ASD, depression, and bipolar disorders, attenuate the binding of GPR50 to LC3 and the mitochondrial recruitment of GPR50, impairing GPR50-mediated mitophagy and neuronal development (Fig. 7F).